Authors: Arkin, S Blei, F Fetten, J Foulke, R Gilchrist, GS Heisel, MA Key, N Kisker, CT Kitchen, C Shafer, FE Shah, PC Strickland, D

Citation: S. Arkin et al., Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven (R) emergency-use programme in patients with severe haemophilia or with acquired inhibitors, BL COAG FIB, 11(3), 2000, pp. 255-259

Authors: Kreis, W Budman, DR Fetten, J Gonzales, AL Barile, B Vinciguerra, V

Citation: W. Kreis et al., Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma, ANN ONCOL, 10(1), 1999, pp. 33-38

Authors: Bayer, RL Lichtman, SM Allen, SL Budman, DR Buchbinder, A Fetten, J Kolitz, J Loscalzo, J

Citation: Rl. Bayer et al., Acquired factor VIII inhibitors - Successful treatment with an oral outpatient regimen, AM J HEMAT, 60(1), 1999, pp. 70-71